Peripheral Arterial Disease
Conditions
Keywords
Peripheral Arterial Disease, Adapted Physical Activity, maximum walking distance
Brief summary
The prevalence of peripheral arterial disease is 12.2% in France. Intermittent claudication is the most common symtom of this disease. During physical exercise, such as walking, blood oxygen (O2) requirements increase. The development of atherosclerosis in the lower limbs, causes narrowing of the arteries and limits the increase in blood flow required for muscular effort. Patients then experience muscle pain, the intensity of which gradually increases until it forces them to stop. After stopping, the pain subsides and disappears in less than 10 minutes. The location of the pain (calves and/or thighs and/or buttocks) is related to the location of the ischemia (distal in the calf, proximal in the thigh or buttock, or proximo-distal if several locations). This can have different consequences on the biomechanical parameters of walking and muscle activity. To date, the impact of this localization on physical capacity has never been studied. These limitations are very disabling and impact the quality of life of patients. In addition, poor lower limb performance is associated with higher mortality. Reducing symptomatology and improving functional abilities is therefore a major issue in patients with peripheral arterial disease. This can be achieved through the practice of an Adapted Physical Activity, an essential recommendation in the care of patients with peripheral arterial disease. Our main hypothesis is that the physical activity rehabilitation protocol "Activ'AO" will improve the functional capacities of patients with peripheral arterial disease who have followed the program with the localization of ischemia with a greater consideration than in patients in the group following a "standard" APA protocol. Improvements in functional abilities (such as walking) will lead to improvements in quality of life.
Interventions
OTHERmuscle strengthening targeted on ischemic areas
muscle strengthening targeted on ischemic areas
OTHERglobal muscle strenghtening
global muscle strenghtening
Sponsors
Centre Hospitalier le Mans
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Two parallel arms
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient with Lower Limb Peripheral Arterial Disease with IPSC \< 0.90, arterial stenosis in the lower limbs and intermittent claudication * No contraindication to physical activity * Socially insured patients over 18 ; * Patient who has signed the consent form.
Exclusion criteria
* Severe or unstable cardiopulmonary pathologies, contraindicating exercise training * Unstable angina or myocardial infarction \<3 months * Severe rheumatological pathology of the lower limbs * Amputee of a lower or upper limb fitted with a device * Extensive dermatosis of the lower limbs * Known NYHA grade III or IV heart failure * Known severe respiratory pathology * Parkinson's disease, hemiplegia or paraplegia * Adults subject to enhanced protection, deprived of their liberty by judicial or administrative decision * Persons unable to consent * Be in a period of exclusion from other interventional research. * Any event (injury, surgery, etc.) occurring during the protocol period that could have an impact on results.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assess efficacity of Adapted Physical Activity with localization of ischemia on maximum walking distance compared to Adapted Physical activity without localization of ischemia | 12 weeks after inclusion | The efficacity of Adapted Physical Activity was assessed by measure of maximum walking distance |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assess efficacity of Adapted Physical Activity with localization of ischemia on walking abilities compared to Adapted Physical activity without localization of ischemia | 12 weeks after inclusion | The efficacity of Adapted Physical Activity was assessed by measure of walking speed with actimeter |
| Assess efficacity of Adapted Physical Activity with localization of ischemia on static balance compared to Adapted Physical activity without localization of ischemia | 12 weeks after inclusion | The efficacity of Adapted Physical Activity was assessed by measure of balance static with stabilometry Platform. |
| Assess quality of Life | At week 12 | Assess quality of life with the "Vascular Quality of Life" questionnaire, and physical activity levels with the "Global Physical Activity Questionnaire". |
| Assess strength capacities | 12 weeks after inclusion | The efficacy of Adapted Physical Activity on strength capacities is measured using grip strength, dynamometers and the chair lift test |
| Assess neuromuscular activity | 12 weeks after inclusion | The efficacy of Adapted Physical Activity on neuromuscular activity is measured using surface electromyography |
Countries
France
Contacts
CONTACTChristelle JADEAU
CONTACTKarine MONTACLAIR
Outcome results
None listed